Related Experiment Videos
[Bilateral angle-closure glaucoma induced by topiramate]
O Beaudry1, V Goncette2, N Collignon1
1Service d'Ophtalmologie, CHR Citadelle, Liège, Belgique.
Revue Medicale De Liege
|April 8, 2017
Abstract:
Topiramate (TPM) is a drug used in migraine prophylaxis. It is involved in the bilateral angle-closure glaucoma due to idiosyncratic response. This side effect is rare but can lead to irreversible vision loss if it is not recognized in time and if it is not managed immediately by an ophthalmologist.